Freestone Grove Partners’s Altimmune ALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-14,418
Closed -$104K 579
2024
Q4
$104K Buy
+14,418
New +$104K ﹤0.01% 561